5 International Banking Apps to Purchase in 2017
Similar to what’s happening in the food sector with the increasing popularity of mobile delivery apps, it has been predicted that we will start to use mobile banking apps 10 times more often than we ... [Read]
A Crash in the Cryptocurrency Industry Might Actually Be a Good Thing
Many seem to forget that cryptocurrencies have only been around for a decade or so. Since then, the trajectory has been largely one of influence. For instance, Bitcoin, one of the earliest digital currencies in ... [Read]
This is Why Ocular Therapeutix Inc.’s Stock Today Fell Despite its Rising Yesterday — July 12, 2017
Ocular Therapeutix’s (NASDAQ:$OCUL) stock fell again on July 12 by 20.5% as of 12:55 PM EDT. The stock fell after news broke out that Ocular received a complete response letter (CRL) for its lead drug ... [Read]
North Dakota Health Department Sets Tentative Timeline For Medical Marijuana Sector
It has been reported that state health officials have set a tentative timeline for initiating a medical cannabis sector in North Dakota, with an end goal of having the drug available to patients in the ... [Read]
Uranium Energy Corp Now Has Full Ownership of the Alto Parana Property
Shares in Uranium Energy Corp. (NYSEMKT:$UEC) increased on July 10 after the junior miner and exploration firm announced that it had exercised a previously disclosed option to acquire CIC Resources. Under the terms of the ... [Read]
Should You Invest in Gold Right Now?
Even though gold prices might be under a bit of pressure from the current “risk-on” environment for equities and rising interest rates, there are a number of analysts who predict that the price will recover ... [Read]
Arena Pharmaceuticals Shares Gained 45% Today
If you’re looking for pharmaceutical companies to invest in, you might want to brush up on what’s been happening in the sector as of late. After Arena Pharmaceuticals (NASDAQ:$ARNA) announced that its experimental pulmonary arterial ... [Read]
An Analyst Upgraded TherapeuticsMD Stock from “Perform” to “Outperform” Today
On Tuesday, after Jay Olson, an analyst at Oppenheimer, upgraded TherapeuticsMD (NYSEMKT:$TXMD) stock from “Perform” to “Outperform”, shares of TXMD increased 18%. Additionally, the analyst gave TherapeuticsMD shares a $10 price target, which means that ... [Read]
This Is Why Ocular Therapeutix Inc.’s Stock Hit the Ceiling Today – July 11, 2017
A few days ago, shares of biopharmaceutical startup Ocular Therapeutix (NASDAQ:$OCUL) were plummeting — but on July 11, the company’s shares shot up by 26%. This is largely due to the fact that Ocular Therapeutix ... [Read]
This is Why Abercrombie & Fitch’s Stock Dropped 21% Today – July 10, 2017
Once famous teen retailer Abercrombie & Fitch (NYSE:$ANF) saw its stock fall by about 21% on July 10, 2017. The plummet in price can be largely attributed to the retailer’s termination of a deal to ... [Read]